KAM

Krensavage Asset Management Portfolio holdings

AUM $189M
This Quarter Return
+6.37%
1 Year Return
+19.71%
3 Year Return
+56.44%
5 Year Return
+120.01%
10 Year Return
+215.64%
AUM
$178M
AUM Growth
+$178M
Cap. Flow
-$51.9M
Cap. Flow %
-29.1%
Top 10 Hldgs %
98.57%
Holding
14
New
1
Increased
3
Reduced
9
Closed
1

Top Buys

1
INDV icon
Indivior
INDV
$6.84M
2
ENTA icon
Enanta Pharmaceuticals
ENTA
$2.56M
3
JAZZ icon
Jazz Pharmaceuticals
JAZZ
$132K
4
MURA icon
Mural Oncology
MURA
$2.53K

Top Sells

1
TARO
Taro Pharmaceutical Industries Ltd.
TARO
$28M
2
EXEL icon
Exelixis
EXEL
$10.3M
3
REGN icon
Regeneron Pharmaceuticals
REGN
$7.88M
4
UTHR icon
United Therapeutics
UTHR
$6.41M
5
BNTX icon
BioNTech
BNTX
$4.6M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
UTHR icon
1
United Therapeutics
UTHR
$13.8B
$36M 20.15% 100,332 -17,876 -15% -$6.41M
EXEL icon
2
Exelixis
EXEL
$10.1B
$33.3M 18.64% 1,281,612 -395,781 -24% -$10.3M
CAH icon
3
Cardinal Health
CAH
$35.5B
$23.2M 13.02% 210,263 -7,393 -3% -$817K
BIIB icon
4
Biogen
BIIB
$19.4B
$22M 12.33% 113,502 -10,283 -8% -$1.99M
ENTA icon
5
Enanta Pharmaceuticals
ENTA
$180M
$15.5M 8.7% 1,498,074 +246,736 +20% +$2.56M
JAZZ icon
6
Jazz Pharmaceuticals
JAZZ
$7.75B
$12.3M 6.88% 110,257 +1,181 +1% +$132K
BNTX icon
7
BioNTech
BNTX
$24B
$11.1M 6.23% 93,583 -38,710 -29% -$4.6M
SNY icon
8
Sanofi
SNY
$121B
$8.66M 4.85% 150,205 -3,627 -2% -$209K
ALKS icon
9
Alkermes
ALKS
$4.78B
$7.04M 3.94% 251,495 -6,059 -2% -$170K
INDV icon
10
Indivior
INDV
$3.03B
$6.84M 3.83% +701,873 New +$6.84M
VNDA icon
11
Vanda Pharmaceuticals
VNDA
$279M
$1.95M 1.09% 414,684 -247,482 -37% -$1.16M
REGN icon
12
Regeneron Pharmaceuticals
REGN
$61.5B
$371K 0.21% 353 -7,500 -96% -$7.88M
MURA icon
13
Mural Oncology
MURA
$35.7M
$237K 0.13% 75,868 +811 +1% +$2.53K
TARO
14
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
– – -650,089 Closed -$28M